Today, one in four or five women in Ontario will give birth through a cesarean or “C-section.” A new study, led by researchers from St…
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — The federal government issued a final rule aimed at preventing insurers from drastically raising insurance premiums; an FDA panel recommends new rules to prevent young kids from overdosing on acetaminophen; and the FDA okays a second drug to treat a rare type of pancreatic cancer.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has cleared the first nucleic acid amplification test that detects and identifies Coxiella burnetii, the bacteria that causes Q fever, in overseas military personnel.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has cleared the first nucleic acid amplification test that detects and identifies Coxiella burnetii, the bacteria that causes Q fever, in overseas military personnel.
No Comments »
Filed under: Pharmacy News
Eli Lilly and Company announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
No Comments »
Filed under: Pharmacy News
Salix Pharmaceuticals, Ltd. today announced findings from two analyses of a Phase 3 open-label study of RELISTOR (methylnaltrexone bromide) presented at the 30th Annual Scientific Meeting of the American Pain Society. The meeting is being held in Austin, TX, on May 19-21, 2011.
No Comments »
Filed under: Pharmacy News
Bristol-Myers Squibb Company, a leading global BioPharma company in oncology, today announced that more than 95 scientific abstracts on its approved and investigational oncology compounds will be featured at the 47th Annual Meeting of the American Society of Clinical Oncology in Chicago from June 3-7.
No Comments »
Filed under: Pharmacy News
Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and SGN-75 programs will be reported at the upcoming American Society of Clinical Oncology 2011 Annual Meeting being held June 3-7, 2011 in Chicago, IL.
No Comments »
Filed under: Pharmacy News
The US Food and Drug Administration (FDA) approved EDURANTTM (rilpivirine) tablets for use in combination with other antiretroviral agents (ARVs) in the treatment of human immunodeficiency virus type 1 (HIV-1) in adults who have never taken HIV therapy (treatment naïve)…
No Comments »
Filed under: Pharmacy News
Abbott announced that it has received approval from the U.S. Food and Drug Administration to market its RealTime PCR (polymerase chain reaction) test for measuring the viral load of hepatitis C (HCV), the leading cause of liver cancer in the United States…
No Comments »
Filed under: Pharmacy News
